|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.99 EUR | +0.67% |
|
+8.00% | -64.73% |
| 06-24 | Biofrontera Announces the Launch of A New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp | CI |
| 05-31 | Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Biofrontera AG reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 3.71 million compared to EUR 5.8 million a year ago. Net loss was EUR 2.71 million compared to EUR 3.48 million a year ago.
Basic loss per share from continuing operations was EUR 0.84. Diluted loss per share from continuing operations was EUR 0.84.
| 1st Jan change | Capi. | |
|---|---|---|
| -64.73% | 19.32M | |
| +55.31% | 815B | |
| +44.25% | 654B | |
| -6.47% | 354B | |
| +21.95% | 337B | |
| +10.67% | 302B | |
| +18.45% | 247B | |
| +2.09% | 229B | |
| +13.03% | 219B | |
| +9.53% | 171B |
BIOFRONTERA AG 
